Success Metrics

Completion Rate
0%(0/1)
Active Trials
5(63%)
Terminated
1(13%)

Phase Distribution

Ph phase_2
4
50%
Ph phase_4
1
13%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Terminated(2)
Other(1)

Detailed Status

Recruiting4
Active, not recruiting1
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (80.0%)
Phase 41 (20.0%)

Trials by Status

active_not_recruiting113%
recruiting450%
terminated113%
withdrawn113%
unknown113%

Recent Activity

5 active trials
Showing 5 of 8
recruitingphase_2

Radioembolization Versus External Radiation Therapy

NCT07530172
recruitingphase_2

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

NCT06860815
active_not_recruiting

A Prospective Observational Study on Efficacy of TARE for Early Stage HCC

NCT07278102
recruitingphase_2

CapTemY90 for Grade 2/3 NET Liver Metastases

NCT04339036
withdrawnphase_2

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

NCT04931420
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07530172Phase 2

Radioembolization Versus External Radiation Therapy

Recruiting
NCT06860815Phase 2

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Recruiting
NCT07278102

A Prospective Observational Study on Efficacy of TARE for Early Stage HCC

Active Not Recruiting
NCT04339036Phase 2

CapTemY90 for Grade 2/3 NET Liver Metastases

Recruiting
NCT04931420Phase 2

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

Withdrawn
NCT04315883

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Terminated
NCT06257030

The AMARA (As Much As Reasonably Achievable) Study

Recruiting
NCT02729506Phase 4

Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma

Unknown

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8